ETFs Holding KYTH »    KYTH Historical Stock Prices »
KYTH News Video: Tue, Mar 11, 2014, 3:20 PM — Tuesday Sector Leaders: Drugs, Gaming

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Kythera Biopharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of prescription products for the aesthetic medicine market. Co.'s focus is on the facial aesthetics market, which comprises the majority of the aesthetic medicine market. Co.'s product candidate, ATX-101, is an injectable drug in late-stage clinical development for the treatment of submental fullness associated with submental fat, which commonly presents as an undesirable double chin. Self directed investors in Kythera Biopharmaceuticals, Inc. will be interested in keeping up with all Kythera Biopharmaceuticals, Inc. news they can find, both KYTH news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on KYTH. At RediNews, we simplify this task by presenting both KYTH news releases originating from Kythera Biopharmaceuticals, Inc. itself, and KYTH news from a variety of media outlets. Visitors can browse this news online and through our KYTH RSS news feed.


KYTH News — Articles, Videos, & Press Releases

KYTH is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

STJ News

RediNews would like to be your web content provider of choice for news feeds by stock ticker symbol, or by market sector. An ideal complement to other financial content like stock quotes and charts, our news gives your users what they want — to see what is being published about the stocks they own, and what the companies themselves are publishing. Simply navigate to any RediNews news page by specific ticker symbol, then click the RSS icon for any news page to reach the associated RSS feed (the icon will look like this): . There is no charge to use our feeds, they are available to you for free.

KYTH News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.